Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Aikawa

Showing results (141-150 of 217) with videos related to

Pageof 22
Sort By:
Journal of Clinical Gastroenterology|January 1, 1994
Biochemical and histological changes after more than four years of treatment of ursodeoxycholic acid in primary biliary cirrhosisY Matsuzaki, M Doy, N Tanaka, et al.
Auris, Nasus, Larynx|January 1, 1984
Relationship between ototoxicity of aminoglycoside antibiotics and their transferability into inner ear fluidsI Ohtani, K Ohtsuki, T Aikawa, et al.
Nihon Jibiinkoka Gakkai Kaiho|November 20, 1980
[Ototoxicity of aminoglycoside antibiotics by rapid intravenous injection (author's transl)]I Ohtani, K Ohtsuki, T Aikawa, et al.
British Journal of Haematology|October 1, 1993
Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocationH Komatsu, K Yoshida, M Seto, et al.
Nihon Hifuka Gakkai Zasshi. the Japanese Journal of Dermatology|February 1, 1984
[Immunologic abnormalities in localized scleroderma]K Takehara, Y Nakabayashi, Y Ishibashi, et al.
Journal of Gastroenterology and Hepatology|April 1, 1996
Cold activation of complement in sera from patients with persistent hepatitis C virus infection on interferon therapyT Aikawa, I Kimura, M Kojima, et al.
The Journal of Toxicological Sciences|November 1, 1992
[A 52-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 8 weeks]S Okazaki, S Nishimura, K Tamura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1992
[A comparative study with 5'-DFUR alone or in combination with tamoxifen (TAM) or medroxyprogesterone acetate (MPA) for advanced or recurrent breast cancer]Y Takatsuka, E Yayoi, K Miyauchi, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|January 1, 1985
Low ototoxicity and its mechanism of netilmicinI Ohtani, K Ohtsuki, T Aikawa, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|January 1, 1985
Protective effect of fosfomycin against aminoglycoside ototoxicityI Ohtani, K Ohtsuki, T Aikawa, et al.
Pageof 22

Showing results (141-150 of 217) with videos related to

Sort By:
Pageof 22
Journal of Clinical Gastroenterology|January 1, 1994
Biochemical and histological changes after more than four years of treatment of ursodeoxycholic acid in primary biliary cirrhosisY Matsuzaki, M Doy, N Tanaka, et al.
Auris, Nasus, Larynx|January 1, 1984
Relationship between ototoxicity of aminoglycoside antibiotics and their transferability into inner ear fluidsI Ohtani, K Ohtsuki, T Aikawa, et al.
Nihon Jibiinkoka Gakkai Kaiho|November 20, 1980
[Ototoxicity of aminoglycoside antibiotics by rapid intravenous injection (author's transl)]I Ohtani, K Ohtsuki, T Aikawa, et al.
British Journal of Haematology|October 1, 1993
Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocationH Komatsu, K Yoshida, M Seto, et al.
Nihon Hifuka Gakkai Zasshi. the Japanese Journal of Dermatology|February 1, 1984
[Immunologic abnormalities in localized scleroderma]K Takehara, Y Nakabayashi, Y Ishibashi, et al.
Journal of Gastroenterology and Hepatology|April 1, 1996
Cold activation of complement in sera from patients with persistent hepatitis C virus infection on interferon therapyT Aikawa, I Kimura, M Kojima, et al.
The Journal of Toxicological Sciences|November 1, 1992
[A 52-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 8 weeks]S Okazaki, S Nishimura, K Tamura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1992
[A comparative study with 5'-DFUR alone or in combination with tamoxifen (TAM) or medroxyprogesterone acetate (MPA) for advanced or recurrent breast cancer]Y Takatsuka, E Yayoi, K Miyauchi, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|January 1, 1985
Low ototoxicity and its mechanism of netilmicinI Ohtani, K Ohtsuki, T Aikawa, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|January 1, 1985
Protective effect of fosfomycin against aminoglycoside ototoxicityI Ohtani, K Ohtsuki, T Aikawa, et al.
Pageof 22